DOI:
10.1055/s-00000142
Frauenheilkunde up2date
LinksClose Window
References
Gianni L, Pienkowski T, Im YH et al.
Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with
locally advanced, inflammatory, or early HER2-positive breast cancer
(NeoSphere): a randomised multicentre, open-label, phase 2 trial.
Lancet Oncology 2012;
13: 25-32
We do not assume any responsibility for the contents of the web pages of other providers.